165 related articles for article (PubMed ID: 9788631)
1. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression.
Wilentz RE; Geradts J; Maynard R; Offerhaus GJ; Kang M; Goggins M; Yeo CJ; Kern SE; Hruban RH
Cancer Res; 1998 Oct; 58(20):4740-4. PubMed ID: 9788631
[TBL] [Abstract][Full Text] [Related]
2. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.
Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH
Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191
[TBL] [Abstract][Full Text] [Related]
3. p16(INK4a) alterations in chronic pancreatitis-indicator for high-risk lesions for pancreatic cancer.
Gerdes B; Ramaswamy A; Kersting M; Ernst M; Lang S; Schuermann M; Wild A; Bartsch DK
Surgery; 2001 Apr; 129(4):490-7. PubMed ID: 11283541
[TBL] [Abstract][Full Text] [Related]
4. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.
Moskaluk CA; Hruban RH; Kern SE
Cancer Res; 1997 Jun; 57(11):2140-3. PubMed ID: 9187111
[TBL] [Abstract][Full Text] [Related]
5. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K
Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas.
Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H
Hepatogastroenterology; 2001; 48(39):879-83. PubMed ID: 11462947
[TBL] [Abstract][Full Text] [Related]
7. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
Wada K
J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical [corrected] detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies: correlation with p16(INK4a) expression.
Geradts J; Wilentz RE; Roberts H
Mod Pathol; 2001 Nov; 14(11):1162-8. PubMed ID: 11706079
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
Hu YX; Watanabe H; Ohtsubo K; Yamaguchi Y; Ha A; Okai T; Sawabu N
Clin Cancer Res; 1997 Sep; 3(9):1473-7. PubMed ID: 9815833
[TBL] [Abstract][Full Text] [Related]
10. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH
Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454
[TBL] [Abstract][Full Text] [Related]
11. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
Tomaszewska R
Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
[TBL] [Abstract][Full Text] [Related]
12. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
13. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
[TBL] [Abstract][Full Text] [Related]
14. [Molecular pathways of pancreatic carcinogenesis].
Torrisani J; Buscail L
Ann Pathol; 2002 Oct; 22(5):349-55. PubMed ID: 12483152
[TBL] [Abstract][Full Text] [Related]
15. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H
Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944
[TBL] [Abstract][Full Text] [Related]
16. [Precursors to pancreatic cancer].
Søreide K; Immervoll H; Molven A
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.
Andea A; Sarkar F; Adsay VN
Mod Pathol; 2003 Oct; 16(10):996-1006. PubMed ID: 14559982
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of pancreatic cancer.
Inoue S; Tezel E; Nakao A
Hepatogastroenterology; 2001; 48(40):933-8. PubMed ID: 11490843
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
